Stocks and Investing
Stocks and Investing
Mon, June 26, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gavin Scott Maintained (BMEA) at Buy with Increased Target to $51 on, Jun 26th, 2023
Gavin Scott of JP Morgan, Maintained "Biomea Fusion, Inc." (BMEA) at Buy with Increased Target from $38 to $51 on, Jun 26th, 2023.
Gavin has made no other calls on BMEA in the last 4 months.
There are 2 other peers that have a rating on BMEA. Out of the 2 peers that are also analyzing BMEA, 0 agree with Gavin's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Gavin
- Peter Lawson of "Barclays" Initiated at Buy and Held Target at $50 on, Friday, May 12th, 2023
- Hartaj Singh of "Oppenheimer" Reiterated at Buy and Held Target at $47 on, Tuesday, April 11th, 2023
Contributing Sources